e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Latest GOLD update
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmacological treatment
N. Roche (Paris, France)
Source:
International Congress 2017 – Latest GOLD update
Session:
Latest GOLD update
Session type:
Session
Number:
3179
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Roche (Paris, France). Pharmacological treatment. International Congress 2017 – Latest GOLD update
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pharmacological treatments
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021
Pharmacological management
Source: Eur Respir Monogr 2016; 71: 196-217
Year: 2016
Pharmacological approach
Source: Annual Congress 2006 - The critically ill patient: chronic obstructive lung disease
Year: 2006
Pharmacological prevention of VAP
Source: Annual Congress 2003 - The diagnosis and prevention of ventilator-associated pneumonia
Year: 2003
Pharmacological and Non-pharmacological therapies that modulare lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021
Treatment of COPD: from pharmacological to instrumental therapies
Source: Eur Respir Rev 2009; 19: 7-23
Year: 2010
Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007
Pharmacological induction of A20: Anti-inflammatory effects in paediatric asthma
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Pharmacological treatment & current controversies in asthma
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019
Pharmacological properties of a novel PI3Kd inhibitor, DS-1515
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Non-pharmacological treatment
Source: ERS Online Course 2016
Year: 2016
Non-pharmacological treatment
Source: International Congress 2017 – Latest GOLD update
Year: 2017
AZD5069: Pharmacological profile of a CXCR2 antagonist in development for the treatment of respiratory disorders
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept